Content about Daclizumab

May 23, 2010

Swiss biotech company Biogen Idec and U.S. drug maker Abbott have begun enrolling patients in...

March 9, 2010

Abbott will acquire Facet Biotech for $450 million, the drug maker announced Wednesday....